Skip to content
Huberman LabHuberman Lab

Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson

Dr. Chris Thompson, MD, Professor of Medicine at Harvard Medical School, Chief of Interventional Gastroenterology at Mass General Brigham in Boston, and Co-Director of the Center for Weight Management and Wellness, is a world-renowned expert on gastroenterology, metabolism, nutrition, and obesity medicine. He explains how your GI tract regulates hunger, fullness, and blood sugar, as well as the gut microbiome, metabolic health, and weight loss. We also discuss common GI tract issues and which particular tests or interventions are actually useful. We discuss both GLP-1 medications and non-GLP-1 approaches to weight loss. Given that gut health is vital to all the organs of the body, overall health, and longevity, our discussion ought to be of interest and practical value to everyone, including, of course, those struggling with gut health or weight loss challenges. Show notes: https://go.hubermanlab.com/moMYULJ Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Lingo: https://hellolingo.com/huberman LMNT: https://drinklmnt.com/huberman Our Place: https://fromourplace.com/huberman Timestamps 00:00:00 Dr. Chris Thompson 00:02:16 Digestive Tract, Gut Hormones & Nutrient Absorption 00:08:06 Colon Microbiome & Colon Cancer Screening 00:11:13 Sponsors: LMNT & Lingo 00:13:40 Swallowing Problems & Zenker’s Diverticula 00:16:08 Bowel Movements & Constipation 00:18:28 Fiber, Resistant Starch & the Gut Barrier 00:21:50 Intermittent Fasting & the Gut Microbiome 00:23:38 Fermented Foods, Microbial Diversity & Butyrate 00:27:12 H. pylori, Stress & Stomach Ulcers 00:30:20 GLP-1 Medications: Benefits & Limitations 00:33:42 Lower GLP-1 Doses, Weight Regain & Muscle Loss 00:37:35 GLP-1 Side Effects, Food Noise & Apathy 00:39:49 Bariatric Surgery & Medical Innovation 00:46:07 Sponsor: AG1 00:47:44 Hunger & Satiety: Ghrelin, CCK, GIP & GLP-1 00:50:01 Retatrutide & Combining Hormonal Targets 00:52:55 Ultra-Processed Foods, Overeating & Leptin 00:55:32 Incretin Discovery, Exendin-4 & the Gila Monster 00:59:35 Endoscopic Ultrasound & Pancreatic Biopsy 01:07:40 Early Metabolic Markers, CGMs & Fasting Insulin 01:13:06 Insulin Resistance & Metabolic Flexibility 01:15:53 Sponsor: Function 01:17:35 Patient Data, Screening & Treatment Adoption 01:26:31 AI, Robotics & Improving Procedures 01:29:27 Choosing a Surgeon & Measuring Procedure Quality 01:35:29 Image Guidance & Hyperspectral Imaging 01:37:19 Sponsor: Our Place 01:38:56 Diagnostics & Targeted Metabolic Treatments 01:42:45 Gastric Bypass, Foregut Exclusion & Diabetes 01:47:59 Duodenal Liners & Mucosal Resurfacing Research 01:52:58 Gut Permeability, Inflammation & Fatty Liver 01:59:39 Artificial Sweeteners, Fructose, Fats & Omega-3s 02:05:00 Resistance Training, Zone 2 Cardio & Intervals 02:06:31 Weight Set Point & Metabolic Adaptation 02:08:13 Endoscopic Sleeve Gastroplasty & Fundus Ablation 02:10:30 Magnetic Intestinal Connections & Combined Treatments 02:16:52 GLP-1 Gene Therapy Research 02:22:13 Innovation, Problem Solving & Teamwork 02:25:58 Zero-Cost Support, Sponsors & Neural Network Newsletter #hubermanlab #science #guthealth Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer

Dr. Chris ThompsonguestAndrew Hubermanhost
Sep 21, 20262h 27mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Gut health tools, microbiome basics, and next-generation obesity treatments explained

  1. Dr. Thompson breaks down the digestive tract as a series of specialized compartments (esophagus, stomach, small bowel, colon) that handle transport, digestion, absorption, microbial metabolism, and hormone signaling.
  2. He emphasizes fiber and fermented foods as foundational tools for microbiome health, butyrate production, and maintenance of the gut barrier (tight junctions and mucus layer).
  3. He describes common clinical issues—from swallowing disorders (achalasia, Zenker’s diverticulum) to constipation and colon-cancer screening—and explains practical thresholds for when symptoms warrant evaluation.
  4. He evaluates GLP-1 medications as transformative but imperfect, highlighting adherence problems, nausea, and muscle loss, and discusses strategies like lower-dose maintenance and pairing drugs with resistance training or procedures.
  5. He outlines next-generation metabolic interventions: minimally invasive endoscopic procedures, AI/robotic assistance for safer and more standardized care, and emerging gene-therapy approaches for nutrient-responsive GLP-1 expression.

IDEAS WORTH REMEMBERING

5 ideas

Fiber “feeds” the microbiome and helps protect the gut barrier.

Thompson explains that dietary fiber is the primary fuel for beneficial gut microbes; when fiber is scarce, microbes can shift toward degrading the gut’s mucus layer. That can reduce butyrate production, weakening tight junction integrity and potentially worsening inflammation and metabolic health.

Bowel-movement patterns are a simple, underused health metric.

He gives a practical rule of thumb: fewer than three bowel movements per day and not going longer than three days without one; hard, pebble-like stools are a common sign of inadequate fiber intake. Stool appearance can also signal bleeding (dark, tarry stools) and other issues worth medical evaluation.

Fermented foods can enhance microbial diversity and inflammation control.

Low-sugar fermented foods (e.g., kefir, kimchi, sauerkraut, yogurt) may improve microbiome diversity and lower inflammatory markers, complementing fiber. He describes them as both “prebiotic” (feeding microbes) and mildly “probiotic” (bringing in live cultures), supporting butyrate-producing cross-feeding in the colon.

Intermittent fasting is usually net-positive, especially for insulin regulation.

Thompson views time-restricted eating/intermittent fasting as generally beneficial for metabolic health because it can reduce chronically elevated insulin exposure. He acknowledges the microbiome may change during fasting but believes the overall metabolic benefits typically outweigh concerns in most people.

GLP-1s work, but muscle loss and long-term adherence are major constraints.

He’s grateful GLP-1 drugs exist but emphasizes limitations: high discontinuation rates, nausea, and muscle loss (including sarcopenia risk) are key reasons people stop or struggle. He notes repeated on/off cycling can worsen body composition because weight regain is disproportionately fat, not lean mass.

WORDS WORTH SAVING

5 quotes

Feed your microbes, you know? They need to be fed. And what they eat is fiber, okay? That's what you want them eating. You want them eating fiber. And if you're not feeding them fiber, they'll eat your mucus layer, okay?

Dr. Chris Thompson

The lining is one cell thick. That's the barrier.

Dr. Chris Thompson

If you stop the GLP-1s, there's problems, right? This is not meant to, to be stopped. These are kind of lifelong medicines.

Dr. Chris Thompson

So say you come off of it and you put your weight back on, you're not putting the lean mass back on, okay? You're putting the fat back on.

Dr. Chris Thompson

Well, increased gut permeability is 100% real.

Dr. Chris Thompson

Digestive tract functions by compartmentGut hormones: ghrelin, CCK, GIP, GLP-1, PYY, leptinFiber, resistant starch, butyrate, tight junctionsFermented foods and microbiome diversityConstipation and stool-quality rules of thumbColon-cancer screening options (colonoscopy, stool DNA tests)GLP-1 medications: adherence, nausea, muscle loss, microdosing strategies, cycling risks

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.